Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Xenon Pharmaceuticals Inc XENE

Healthcare Biotechnology
Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the... see more

Recent & Breaking News (NDAQ:XENE)

Xenon Pharmaceuticals to Present at the Stifel 2016 Healthcare Conference

GlobeNewswire November 8, 2016

Xenon Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire November 3, 2016

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2016 Financial Results and Provide Corporate Update

GlobeNewswire October 27, 2016

Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors

GlobeNewswire September 27, 2016

The Market In 5 Minutes: Oil, Debates And Epidiolex

Benzinga.com  September 26, 2016

Xenon Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Closing of $34.5 Million Public Offering

GlobeNewswire September 13, 2016

Xenon Pharmaceuticals Announces Pricing of $30 Million Public Offering of Common Shares

GlobeNewswire September 8, 2016

Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

GlobeNewswire September 7, 2016

Xenon Expects XEN801 Results In Q1 2017, Delayed One Quarter

Benzinga.com  August 3, 2016

Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire August 3, 2016

Xenon Pharmaceuticals to Present at the Canaccord Genuity 36th Annual Growth Conference

GlobeNewswire August 2, 2016

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2016 Financial Results and Provide Corporate Update

GlobeNewswire July 25, 2016

Xenon Pharmaceuticals Presents Corporate Update and Highlights Its Proprietary Therapeutic Programs at the Jefferies 2016 Healthcare Conference

GlobeNewswire June 8, 2016

Xenon Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference

GlobeNewswire June 2, 2016

Xenon Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire May 10, 2016

Sportsman's Warehouse Holdings, Inc. Announces First Quarter 2016 Earnings Conference Call

GlobeNewswire May 10, 2016

Symmetry Surgical Inc. to be acquired by RoundTable Healthcare Partners for $13.10 per share in cash

GlobeNewswire May 2, 2016

Xenon Names Dr. Raymond J. Winquist as Head, Translational Research

GlobeNewswire April 4, 2016

Xenon Pharmaceuticals to Provide Business and Milestone Update at Needham Healthcare Conference

GlobeNewswire March 31, 2016

Xenon and Genentech Extend Collaborations Focused on Pain

GlobeNewswire March 15, 2016